Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights

Journal of Gastroenterology, Mar 2016

Changes of hepatic sinusoids are crucial in the pathogenesis of liver cirrhosis and portal hypertension. Liver injury leads to distinct morphological abnormalities such as loss of sinusoidal fenestration, vasoconstriction, and angiogenesis as well as molecular changes. Communication between the two key cells in this hepatic microenvironment—hepatic stellate cells (HSC) and sinusoidal endothelial cells (SEC)—has been studied for many years and several canonical pathways have been elucidated, such as decreased eNOS activity or increased PDGF and TGF-β production leading to activation and migration of HSC. In recent studies, alternative pathways of intercellular communication in liver diseases have been described such as cell-derived extracellular vesicles called exosomes, which deliver cell compounds to their target cells. Moreover, such extracellular vesicles may link injury to inflammation in alcoholic hepatitis. While inflammation leading to liver fibrosis has been studied in detail, in some circumstances pathways other than the known canonical inflammatory pathways may contribute to hepatic fibrogenesis. For example, in congestive hepatopathy, sinusoidal dilatation and fibrosis have been shown to be mediated by non-inflammatory mechanisms and associated with sinusoidal thrombi. A recently developed murine model further enables experimental studies of this disease entity. Increasing knowledge about these alternative disease pathways in liver injury, inflammation, and fibrosis may reveal possible target molecules for future therapies. This article builds upon a seminar given at the recent 3rd JSGE International Topic Conference in Sendai, Japan, and reviews the areas outlined above.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs00535-016-1190-4.pdf

Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights

J Gastroenterol Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights Thomas Greuter 0 1 2 Vijay H. Shah 0 1 2 0 & Vijay H. Shah 1 Gastroenterology Research Unit, Department of Gastroenterology and Hepatology, Mayo Clinic and Foundation , 200 First St. SW, Rochester, MN 55905 , USA 2 Division of Gastroenterology and Hepatology, University Hospital Zurich , Zurich , Switzerland Changes of hepatic sinusoids are crucial in the pathogenesis of liver cirrhosis and portal hypertension. Liver injury leads to distinct morphological abnormalities such as loss of sinusoidal fenestration, vasoconstriction, and angiogenesis as well as molecular changes. Communication between the two key cells in this hepatic microenvironment-hepatic stellate cells (HSC) and sinusoidal endothelial cells (SEC)-has been studied for many years and several canonical pathways have been elucidated, such as decreased eNOS activity or increased PDGF and TGF-b production leading to activation and migration of HSC. In recent studies, alternative pathways of intercellular communication in liver diseases have been described such as cell-derived extracellular vesicles called exosomes, which deliver cell compounds to their target cells. Moreover, such extracellular vesicles may link injury to inflammation in alcoholic hepatitis. While inflammation leading to liver fibrosis has been studied in detail, in some circumstances pathways other than the known canonical inflammatory pathways may contribute to hepatic fibrogenesis. For example, in congestive hepatopathy, sinusoidal dilatation and fibrosis have been shown to be mediated by non-inflammatory mechanisms and associated with sinusoidal thrombi. A recently developed murine model further enables experimental studies of this disease entity. Increasing knowledge about these alternative disease pathways in liver injury, inflammation, and fibrosis may reveal possible target molecules for future therapies. This article builds upon a seminar given at the recent 3rd JSGE International Topic Conference in Sendai, Japan, and reviews the areas outlined above. Sinusoidal epithelial cell; Hepatic stellate cell; Intercellular communication; Intrasinusoidal thrombosis; Exosome signaling; Microvesicles; Overview of changes in hepatic sinusoids in the pathogenesis of liver cirrhosis and portal hypertension - The hepatic sinusoids with the involved hepatic sinusoidal endothelial cells (SEC), smooth muscle cells, and pericytelike hepatic stellate cells (HSC) form an intrahepatic microcirculatory unit, where these cells are intimately associated with one another and communicate through paracrine and autocrine effects [ 1 ]. Changes in this microenvironment are crucial in the early steps of fibrogenesis and include sinusoidal remodeling, vasoconstriction, endothelial dysfunction, and angiogenesis [ 2 ]. This article provides background information pertaining to the hepatic sinusoids and then focuses on recent developments pertaining to sinusoidal pathobiology, as recently presented at the 3rd JSGE International Topic Conference in Sendai, Japan. Sinusoidal endothelial cells SEC have a very unique phenotype distinct from conventional endothelial cells, characterized by multiple fenestrae and the lack of a basement membrane [ 3?5 ]. Serving as a mechanical sieve, fenestration permits steric selection of transfer from sinusoidal space to hepatic parenchyma [ 6, 7 ]. In addition, SEC show constitutive expression of nitric oxide (NO) synthase, which can be upregulated by increased blood flow and shear stress [8] as well as paracrine factors from other cells such as VEGF [ 9, 10 ]. Through this mechanism known as autoregulation, hepatic sinusoids can adapt to increased intrahepatic blood flow and decrease intrahepatic pressure [8]. Further physiological functions of SEC are leukocyte diapedesis through expression of adhesion molecules, endocytosis (known as the hepatic reticuloendothelial system), and bacterial processing [ 5 ]. As the first cells interacting with portal vein components, SEC are exposed to different bacterial compounds. Bacterially derived lipopolysaccharides (LPS) bind to their receptor TLR-4 expressed on SEC, inducing injury and inflammation [ 11 ]. Interestingly, recent studies have shown that LPS can also induce fibrosis-associated angiogenesis by interacting with TLR-4, highlighting the role of SEC in the so-called gut?liver axis [ 12, 13 ]. In liver disease, the SEC phenotype changes dramatically [ 1, 14 ]. Liver injury leads to endothelial dysfunction with loss of fenestrae and deposition of a basement membrane, a process that is known as capillarization [ 6, 15, 16 ]. Besides these morphological changes, changes in paracrine and autocrine function are dramatic, too. NO production usually decreases, leading to an increasing intrahepatic pressure due to an inability to maintain intrasinusoidal autoregulation by vasodilatation [ 1, 17 (...truncated)


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs00535-016-1190-4.pdf

Thomas Greuter, Vijay H. Shah. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights, Journal of Gastroenterology, 2016, pp. 511-519, Volume 51, Issue 6, DOI: 10.1007/s00535-016-1190-4